A Comparison Between Organic and Inorganic Nanoparticles: Prime Nanoparticles for Tumor Curation

The nano-based therapeutics are prioritized over conventional chemotherapeutics due to their out-standing advantages in cancer therapy. The targeting of the tumor is not specific i.e., they are targeted according to the abundance of biologically active molecules on cell surface or due to the presence of certain receptors making them unique in appearance. The controlled-expression of certain molecules through nano-therapeutics leads tumor cells into normal cells. Both organic and inorganic nanoparticles are biocompatible, nontoxic and highly effective against cancer curation. In the modern era, nanotechnology is one of the rapidly growing fields in many biomedical applications especially in delivering therapeutics for the curation of tumor cells. Cancer is a lethal disease that grows silently in the human body, caused by mutations in the genetic material of cells. The presence of a high number of physiologically active chemicals on the cancer cell surface does not particularly lead to tumor cell targeting. The lack of effective targeting of tumor cells by conventionally administered chemotherapeutic drugs demands the use of nanomedicine. Conventional medicines have immense cytotoxic effects, i.e., they do not kill tumor cells only but also destroy normal body cells. Nanoparticles (NPs) have an advantage over conventional therapeutic methods due to their small size, large surface area, and especially for targeting tumor cells without harming normal body cells. Based on durability and molecular weight, NPs are classified as organic and inorganic nanoparticles. Common organic and inorganic nanoparticles are highly effective against cancer curation and have high efficacy values along with their mechanism of action.